rs368603235
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM1BP4_ModerateBP6
The NM_016239.4(MYO15A):c.4096G>A(p.Asp1366Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000502 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152080Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000641 AC: 16AN: 249560 AF XY: 0.0000591 show subpopulations
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461844Hom.: 0 Cov.: 33 AF XY: 0.0000248 AC XY: 18AN XY: 727224 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000256 AC: 39AN: 152198Hom.: 0 Cov.: 31 AF XY: 0.000309 AC XY: 23AN XY: 74400 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
The p.Asp1366Asn variant in MYO15A has not been previously reported in individua ls with hearing loss. It has been identified in 7/9798 African chromosomes by th e Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs36 8603235). Although this variant has been seen in the general population, its fre quency is not high enough to rule out a pathogenic role. Computational predictio n tools and conservation analysis do not provide strong support for or against a n impact to the protein. In summary, the clinical significance of the p.Asp1366A sn variant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at